IDEAS home Printed from https://ideas.repec.org/f/c/pva780.html
   My authors  Follow this author

Sotiris Vandoros

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:
  1. Vandoros, Sotiris & Avendano, Mauricio & Kawachi, Ichiro, 2019. "The association between economic uncertainty and suicide in the short-run," Social Science & Medicine, Elsevier, vol. 220(C), pages 403-410.

    Mentioned in:

    1. Simon McNamara’s journal round-up for 21st January 2019
      by sjmcnamara1 in The Academic Health Economists' Blog on 2019-01-21 12:00:11

Working papers

  1. van der Windt, Peter Cornelis & Vandoros, Sotiris, 2020. "Democracy and Health: Evidence from Within-Country Heterogeneity in the Congo," SocArXiv kpwxz, Center for Open Science.

    Cited by:

    1. Carr, Olivia G. & Jilani-Hyler, Nadia & Murray, Gregg R., 2022. "Identifying factors related to school closures due to COVID-19 in the Middle East and North Africa region," International Journal of Educational Development, Elsevier, vol. 90(C).

  2. Chris Muris & Pedro Raposo & Sotiris Vandoros, 2020. "A dynamic ordered logit model with fixed effects," Papers 2008.05517, arXiv.org.

    Cited by:

    1. Kevin Dano, 2023. "Transition Probabilities and Moment Restrictions in Dynamic Fixed Effects Logit Models," Papers 2303.00083, arXiv.org, revised Dec 2023.
    2. Bartolucci, Francesco & Pigini, Claudia & Valentini, Francesco, 2022. "Testing for state dependence in the fixed-effects ordered logit model," MPRA Paper 113890, University Library of Munich, Germany.
    3. Bo E. Honoré & Chris Muris & Martin Weidner, 2021. "Dynamic Ordered Panel Logit Models," Working Papers 2021-14, Princeton University. Economics Department..

  3. Georgios Kavetsos & Ichiro Kawachi & Ilias Kyriopoulos & Sotiris Vandoros, 2018. "The effect of the Brexit referendum result on subjective well-being," CEP Discussion Papers dp1586, Centre for Economic Performance, LSE.

    Cited by:

    1. Kyriopoulos, Ilias & Vandoros, Sotiris & Kawachi, Ichiro, 2022. "Police killings and suicide among Black Americans," Social Science & Medicine, Elsevier, vol. 305(C).
    2. Gamage, Danula K. & Kavetsos, Georgios & Mallick, Sushanta & Sevilla, Almudena, 2020. "Pay Transparency Initiative and Gender Pay Gap: Evidence from Research-Intensive Universities in the UK," IZA Discussion Papers 13635, Institute of Labor Economics (IZA).
    3. Hervy, Charlotte & Cavalli, Nicolo & Madia, Joan E. & Nicodemo, Catia, 2022. "Diverging mental health after Brexit: Evidence from a longitudinal survey," Social Science & Medicine, Elsevier, vol. 302(C).
    4. Gamage, Danula K. & Kavetsos, Georgios & Mallick, Sushanta & Sevilla, Almudena, 2023. "Pay transparency intervention and the gender pay gap: evidence from research‐intensive universities in the UK," LSE Research Online Documents on Economics 120850, London School of Economics and Political Science, LSE Library.
    5. Swati Dhingra & Thomas Sampson, 2022. "Expecting Brexit," CESifo Working Paper Series 9541, CESifo.
    6. Saville, Christopher W.N., 2020. "Mental health consequences of minority political positions: The case of brexit," Social Science & Medicine, Elsevier, vol. 258(C).
    7. Rienzo, Cinzia, 2024. "Trick or treat? The Brexit effect on immigrants’ mental health in the United Kingdom," European Economic Review, Elsevier, vol. 162(C).
    8. Drinkwater, Stephen & Blackaby, David H. & Robinson, Catherine, 2024. "What Mattered Most in the Brexit Vote? Evidence from Detailed Regression and Decomposition Analysis," IZA Discussion Papers 16841, Institute of Labor Economics (IZA).
    9. Liew, Tim & Goodwin, Robin & Walasek, Lukasz, 2020. "Voting patterns, revoking article 50 and antidepressant trends in England following the Brexit referendum," Social Science & Medicine, Elsevier, vol. 255(C).
    10. Ichiro Kawachi & Ilias Kyriopoulos & Sotiris Vandoros, 2023. "Economic uncertainty and cardiovascular disease mortality," Health Economics, John Wiley & Sons, Ltd., vol. 32(7), pages 1550-1560, July.

  4. Hessel, Philipp & Vandoros, Sotiris & Avendano, Mauricio, 2014. "The differential impact of the financial crisis on health in Ireland and Greece: a quasi-experimental approach," LSE Research Online Documents on Economics 59610, London School of Economics and Political Science, LSE Library.

    Cited by:

    1. Chen-Mao Liao & Chih-Ming Lin, 2017. "The Effects of the Global Economic Recession and a Reduced Alcohol Tax on Hospitalizations Due to Alcohol-Attributed Diseases in Taiwan," IJERPH, MDPI, vol. 14(6), pages 1-12, May.
    2. Thompson, Kristina & Ophem, Johan van & Wagemakers, Annemarie, 2019. "Studying the impact of the Eurozone’s Great Recession on health: Methodological choices and challenges," Economics & Human Biology, Elsevier, vol. 35(C), pages 162-184.
    3. Petrou, Panagiotis & Vandoros, Sotiris, 2015. "Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment," Health Policy, Elsevier, vol. 119(5), pages 563-568.
    4. Jofre-Bonet, Mireia & Serra-Sastre, Victoria & Vandoros, Sotiris, 2018. "The impact of the Great Recession on health-related risk factors, behaviour and outcomes in England," Social Science & Medicine, Elsevier, vol. 197(C), pages 213-225.
    5. Jofre-Bonet, M. & Serra-Sastre, V. & Vandoros, S., 2016. "Better Health in Times of Hardship?," Working Papers 16/09, Department of Economics, City University London.
    6. Giovanni Piumatti, 2020. "Longitudinal Trends in Self-Rated Health During Times of Economic Uncertainty in Italy," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 148(2), pages 599-633, April.
    7. M. Sáez & J. Vidiella-Martin & Guillem López i Casasnovas, 2018. "Collateral damages of the great crisis in Spain. A longitudinal health study," Economics Working Papers 1603, Department of Economics and Business, Universitat Pompeu Fabra.

  5. Kanavos, Panos & Vandoros, Sotiris, 2011. "Determinants of branded prescription medicine prices in OECD countries," LSE Research Online Documents on Economics 36351, London School of Economics and Political Science, LSE Library.

    Cited by:

    1. Anna-Maria Fontrier & Jennifer Gill & Panos Kanavos, 2019. "International impact of external reference pricing: should national policy-makers care?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(8), pages 1147-1164, November.
    2. Fritz von der Schulenburg & Sotiris Vandoros & Panos Kanavos, 2011. "The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors," Health Economics Review, Springer, vol. 1(1), pages 1-8, December.
    3. Petrou, Panagiotis & Vandoros, Sotiris, 2015. "Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment," Health Policy, Elsevier, vol. 119(5), pages 563-568.
    4. Jennifer Gill & Anna-Maria Fontrier & Dionysis Kyriopoulos & Panos Kanavos, 2019. "Variations in external reference pricing implementation: does it matter for public policy?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(9), pages 1375-1397, December.
    5. WARBURTON, Christopher E.S., 2019. "Uneasy Coexistence: Profit Maximization And Affordable Healthcare In The Us," Applied Econometrics and International Development, Euro-American Association of Economic Development, vol. 19(1), pages 55-80.
    6. Vogler, Sabine & Habimana, Katharina & Arts, Danielle, 2014. "Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries," Health Policy, Elsevier, vol. 117(3), pages 311-327.
    7. Vandoros, Sotiris & Stargardt, Tom, 2013. "Reforms in the Greek pharmaceutical market during the financial crisis," Health Policy, Elsevier, vol. 109(1), pages 1-6.
    8. Simona Gamba & Paolo Pertile & Sabine Vogler, 2020. "The impact of managed entry agreements on pharmaceutical prices," Health Economics, John Wiley & Sons, Ltd., vol. 29(S1), pages 47-62, October.
    9. Jae Ho Jung & Dae Jung Kim & Kangho Suh & Jaeeun You & Je Ho Lee & Kyung In Joung & Dong Churl Suh, 2021. "International Price Comparisons of Anticancer Drugs: A Scheme for Improving Patient Accessibility," IJERPH, MDPI, vol. 18(2), pages 1-14, January.
    10. Sohag, Kazi & Shams, S.M. Riad & Gainetdinova, Anna & Nappo, Fabio, 2023. "Frequency connectedness and cross-quantile dependence among medicare, medicine prices and health-tech equity," Technovation, Elsevier, vol. 120(C).
    11. Puig-Junoy, Jaume & López-Valcárcel, Beatriz González, 2014. "Launch prices for new pharmaceuticals in the heavily regulated and subsidized Spanish market, 1995–2007," Health Policy, Elsevier, vol. 116(2), pages 170-181.
    12. Fontrier, Anna-Maria & Gill, Jennifer & Kanavos, Panos, 2019. "International impact of external reference pricing: should national policy makers care?," LSE Research Online Documents on Economics 100929, London School of Economics and Political Science, LSE Library.
    13. Paolo Pertile & Simona Gamba & Martin Forster, 2018. "Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence," Discussion Papers 18/04, Department of Economics, University of York.
    14. Massimo Florio & Chiara Pancotti, 2022. "European pharmaceutical research and development. Could a public infrastructure overcome market failures?," Working Papers 202202, CSIL Centre for Industrial Studies.
    15. Takizawa, Osamu & Urushihara, Hisashi & Tanaka, Shiro & Kawakami, Koji, 2015. "Price difference as a predictor of the selection between brand name and generic statins in Japan," Health Policy, Elsevier, vol. 119(5), pages 612-619.
    16. Stephan Eger & Jörg Mahlich, 2014. "Pharmaceutical regulation in Europe and its impact on corporate R&D," Health Economics Review, Springer, vol. 4(1), pages 1-9, December.
    17. Dominik J. Wettstein & Stefan Boes, 2019. "Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review," Applied Health Economics and Health Policy, Springer, vol. 17(2), pages 143-162, April.

  6. Vandoros, Sotiris & Carman, Katherine Grace, 2011. "Demand and pricing of preventative healthcare," LSE Research Online Documents on Economics 37159, London School of Economics and Political Science, LSE Library.

    Cited by:

    1. Choi, Pak-Sing & Espinola-Arredondo, Ana & Munoz-Garcia, Felix, 2024. "Environmental regulation under sequential competition," Journal of Economic Behavior & Organization, Elsevier, vol. 221(C), pages 52-72.

Articles

  1. Ichiro Kawachi & Ilias Kyriopoulos & Sotiris Vandoros, 2023. "Economic uncertainty and cardiovascular disease mortality," Health Economics, John Wiley & Sons, Ltd., vol. 32(7), pages 1550-1560, July.

    Cited by:

    1. Ruri Okubo & Ryusuke Matsumoto & Eishi Motomura & Motohiro Okada, 2024. "Uncertainties of Economic Policy and Government Management Stability Played Important Roles in Increasing Suicides in Japan from 2009 to 2023," IJERPH, MDPI, vol. 21(10), pages 1-18, October.
    2. Kanavos, Panos & Vandoros, Sotiris, 2023. "Road traffic mortality and economic uncertainty: Evidence from the United States," Social Science & Medicine, Elsevier, vol. 326(C).
    3. Kyriopoulos, Ilias-Ioannis & Vandoros, Sotiris & Kawachi, Ichiro, 2023. "State-level economic uncertainty and cardiovascular disease deaths: evidence from the United States," LSE Research Online Documents on Economics 120679, London School of Economics and Political Science, LSE Library.
    4. Kyriopoulos, Ilias-Ioannis, 2023. "Economic uncertainty and cardiovascular disease mortality," LSE Research Online Documents on Economics 118452, London School of Economics and Political Science, LSE Library.

  2. Kanavos, Panos & Vandoros, Sotiris, 2023. "Road traffic mortality and economic uncertainty: Evidence from the United States," Social Science & Medicine, Elsevier, vol. 326(C).

    Cited by:

    1. Tomašković Mladen & Završki Ivica, 2024. "Analysis of the road safety in the EU countries and the impact of PBM on its improvement," Organization, Technology and Management in Construction, Sciendo, vol. 16(1), pages 123-135.

  3. Velias, Alina & Georganas, Sotiris & Vandoros, Sotiris, 2022. "COVID-19: Early evening curfews and mobility," Social Science & Medicine, Elsevier, vol. 292(C).

    Cited by:

    1. Apel, Johannes & Rohde, Niklas & Marcus, Jan, 2023. "The effect of a nighttime curfew on the spread of COVID-19," Health Policy, Elsevier, vol. 129(C).
    2. MASUHARA Hiroaki & HOSOYA Kei, 2022. "What Impacts Do Human Mobility and Vaccination Have on Trends in COVID-19 Infections? Evidence from four developed countries," Discussion papers 22087, Research Institute of Economy, Trade and Industry (RIETI).

  4. Kyriopoulos, Ilias & Vandoros, Sotiris & Kawachi, Ichiro, 2022. "Police killings and suicide among Black Americans," Social Science & Medicine, Elsevier, vol. 305(C).

    Cited by:

    1. Quinn, Katherine G. & Edwards, Travonne & Johnson, Anthony & Takahashi, Lois & Dakin, Andrea & Bouacha, Nora & Voisin, Dexter, 2023. "Understanding the impact of police brutality on Black sexually minoritized men," Social Science & Medicine, Elsevier, vol. 334(C).

  5. Georgios Kavetsos & Ichiro Kawachi & Ilias Kyriopoulos & Sotiris Vandoros, 2021. "The effect of the Brexit referendum result on subjective well‐being," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 184(2), pages 707-731, April.
    See citations under working paper version above.
  6. Vandoros, Sotiris, 2020. "Excess mortality during the Covid-19 pandemic: Early evidence from England and Wales," Social Science & Medicine, Elsevier, vol. 258(C).

    Cited by:

    1. Alacevich, Caterina & Cavalli, Nicolò & Giuntella, Osea & Lagravinese, Raffaele & Moscone, Francesco & Nicodemo, Catia, 2020. "Exploring the Relationship between Care Homes and Excess Deaths in the COVID-19 Pandemic: Evidence from Italy," IZA Discussion Papers 13492, Institute of Labor Economics (IZA).
    2. Theologos Dergiades & Costas Milas & Elias Mossialos & Theodore Panagiotidis, 2021. "Effectiveness of Government Policies in Response to the COVID-19 Outbreak," Discussion Paper Series 2021_05, Department of Economics, University of Macedonia, revised Feb 2021.
    3. Simone Ghislandi & Raya Muttarak & Markus Sauerberg & Benedetta Scotti, 2022. "Human costs of the first wave of the COVID-19 pandemic in the major epicentres in Italy," Vienna Yearbook of Population Research, Vienna Institute of Demography (VID) of the Austrian Academy of Sciences in Vienna, vol. 20(1), pages 285-282.
    4. Joshua Aizenman & Alex Cukierman & Yothin Jinjarak & Sameer Nair-Desai & Weining Xin, 2022. "Gaps Between Official and Excess Covid-19 Mortality Measures: The Effects of Institutional Quality and Vaccinations," NBER Working Papers 29778, National Bureau of Economic Research, Inc.
    5. Shiran Bord & Aviad Tur-Sinai & Fuad Basis, 2022. "High Non-COVID-19 in-Hospital Deaths during the First Lockdown in Israel Compared with the Second and Third Lockdowns," IJERPH, MDPI, vol. 19(20), pages 1-11, October.
    6. Ferro, Simone & Riganti, Andrea, 2024. "The hidden toll of the pandemic on nonrespiratory patients," Health Policy, Elsevier, vol. 143(C).
    7. Laliotis, Ioannis & Minos, Dimitrios, 2022. "Religion, social interactions, and COVID-19 incidence in Western Germany," European Economic Review, Elsevier, vol. 141(C).
    8. Augusto Cerqua & Roberta Di Stefano & Marco Letta & Sara Miccoli, 2020. "Local mortality estimates during the COVID-19 pandemic in Italy," Working Papers 14/20, Sapienza University of Rome, DISS.
    9. Lorena Barberia & Thomas Plümper & Guy D. Whitten, 2021. "The political science of Covid‐19: An introduction," Social Science Quarterly, Southwestern Social Science Association, vol. 102(5), pages 2045-2054, September.
    10. Michael Polemis & Thanasis Stengos, 2022. "Life expectancy during the Covid-19 pandemic: A semi-parametric difference-in-differences analysis," Economics Bulletin, AccessEcon, vol. 42(2), pages 360-371.
    11. Caterina Alacevich & Nicolò Cavalli & Osea Giuntella & Raffaele Lagravinese & Francesco Moscone & Catia Nicodemo, 2021. "The presence of care homes and excess deaths during the COVID‐19 pandemic: Evidence from Italy," Health Economics, John Wiley & Sons, Ltd., vol. 30(7), pages 1703-1710, July.
    12. Lili Yan Ing & Juniarto James Losari, 2022. "COVID-19: Impacts of Indonesia's Trade," Working Papers DP-2021-49, Economic Research Institute for ASEAN and East Asia (ERIA).
    13. Subhasish Dey & Jessie Davidson, 2021. "The Determinants of Non-COVID-19 Excess Deaths During the COVID-19 Pandemic: A Cross-country Panel Study," Studies in Microeconomics, , vol. 9(2), pages 196-226, December.
    14. Janette Yung & Jiehui Li & Rebecca D. Kehm & James E. Cone & Hilary Parton & Mary Huynh & Mark R. Farfel, 2022. "COVID-19-Specific Mortality among World Trade Center Health Registry Enrollees Who Resided in New York City," IJERPH, MDPI, vol. 19(21), pages 1-13, November.
    15. Sobol, Małgorzata & Blachnio, Agata & Przepiórka, Aneta, 2020. "Time of pandemic: Temporal perspectives related to compliance with public health regulations concerning the COVID-19 pandemic," Social Science & Medicine, Elsevier, vol. 265(C).

  7. Vandoros, Sotiris & Avendano, Mauricio & Kawachi, Ichiro, 2019. "The association between economic uncertainty and suicide in the short-run," Social Science & Medicine, Elsevier, vol. 220(C), pages 403-410.

    Cited by:

    1. Propper, Carol & Janke, Katharina & Lee, Kevin & Shields, Kalvinder & Shields, Michael A, 2020. "Macroeconomic Conditions and Health in Britain: Aggregation, Dynamics and Local Area Heterogeneity," CEPR Discussion Papers 14507, C.E.P.R. Discussion Papers.
    2. Georgios Kavetsos & Ichiro Kawachi & Ilias Kyriopoulos & Sotiris Vandoros, 2018. "The effect of the Brexit referendum result on subjective well-being," CEP Discussion Papers dp1586, Centre for Economic Performance, LSE.
    3. Federico Belotti & Joanna Kopinska & Alessandro Palma & Andrea Piano Mortari, 2022. "Health status and the Great Recession. Evidence from electronic health records," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1770-1799, August.
    4. Rui Yao & Weipeng Wu, 2022. "Mental Disorders Associated with COVID-19 Related Unemployment," Applied Research in Quality of Life, Springer;International Society for Quality-of-Life Studies, vol. 17(2), pages 949-970, April.
    5. Abdou, Rawayda & Cassells, Damien & Berrill, Jenny & Hanly, Jim, 2022. "Revisiting the relationship between economic uncertainty and suicide: An alternative approach," Social Science & Medicine, Elsevier, vol. 306(C).
    6. Ryusuke Matsumoto & Eishi Motomura & Motohiro Okada, 2024. "Impacts of Working Hours, Wages, and Regular Employment Opportunity on Suicide Mortalities of Employed and Unemployed Individuals before and during the COVID-19 Pandemic in Japan," IJERPH, MDPI, vol. 21(4), pages 1-17, April.
    7. Richardson, Cara & Robb, Kathryn A. & O'Connor, Rory C., 2021. "A systematic review of suicidal behaviour in men: A narrative synthesis of risk factors," Social Science & Medicine, Elsevier, vol. 276(C).
    8. Abdou, Rawayda & Cassells, Damien & Berrill, Jenny & Hanly, Jim, 2020. "An empirical investigation of the relationship between business performance and suicide in the US," Social Science & Medicine, Elsevier, vol. 264(C).
    9. Kanavos, Panos & Vandoros, Sotiris, 2023. "Road traffic mortality and economic uncertainty: Evidence from the United States," Social Science & Medicine, Elsevier, vol. 326(C).
    10. Ferdi Botha & Viet H. Nguyen, 2021. "Opposite Nonlinear Effects of Unemployment and Sentiment on Male and Female Suicide Rates: Evidence from Australia," Melbourne Institute Working Paper Series wp2021n15, Melbourne Institute of Applied Economic and Social Research, The University of Melbourne.
    11. Christoph Kronenberg, 2021. "A New Measure of 19th Century US Suicides," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 157(2), pages 803-815, September.
    12. Subhasish Dey & Jessie Davidson, 2021. "The Determinants of Non-COVID-19 Excess Deaths During the COVID-19 Pandemic: A Cross-country Panel Study," Studies in Microeconomics, , vol. 9(2), pages 196-226, December.
    13. Collins, Alan & Fan, Jingwen & Mahabir, Aruneema, 2022. "Actual versus ‘natural’ rates of suicide: Evidence from the USA," Economic Modelling, Elsevier, vol. 106(C).
    14. Vandoros, Sotiris, 2020. "Excess mortality during the Covid-19 pandemic: Early evidence from England and Wales," Social Science & Medicine, Elsevier, vol. 258(C).
    15. Wen, Qiang & Zhang, Teng, 2022. "Economic policy uncertainty and industrial pollution: The role of environmental supervision by local governments," China Economic Review, Elsevier, vol. 71(C).
    16. Kyriopoulos, Ilias & Nikoloski, Zlatko & Mossialos, Elias, 2019. "Does economic recession impact newborn health? Evidence from Greece," Social Science & Medicine, Elsevier, vol. 237(C), pages 1-1.
    17. Denneson, Lauren M. & Tompkins, Kyla J. & McDonald, Katie L. & Hoffmire, Claire A. & Britton, Peter C. & Carlson, Kathleen F. & Smolenski, Derek J. & Dobscha, Steven K., 2020. "Gender differences in the development of suicidal behavior among United States military veterans: A national qualitative study," Social Science & Medicine, Elsevier, vol. 260(C).
    18. Lepori, Gabriele M. & Morgan, Sara & Assarian, Borna A. & Mishra, Tapas, 2024. "Economic activity and suicides: Causal evidence from macroeconomic shocks in England and Wales," Social Science & Medicine, Elsevier, vol. 342(C).
    19. Claveria, Oscar, 2022. "Global economic uncertainty and suicide: Worldwide evidence," Social Science & Medicine, Elsevier, vol. 305(C).
    20. Karras, Elizabeth & Stokes, Cara M. & Warfield, Sara C. & Barth, Shannon K. & Bossarte, Robert M., 2019. "A randomized controlled trial of public messaging to promote safe firearm storage among U.S. military veterans," Social Science & Medicine, Elsevier, vol. 241(C).
    21. Tao, Hung-Lin & Cheng, Hui-Pei, 2023. "Economic policy uncertainty and subjective health: A gender perspective," Social Science & Medicine, Elsevier, vol. 334(C).
    22. Elisabet Beseran & Juan M. Pericàs & Lucinda Cash-Gibson & Meritxell Ventura-Cots & Keshia M. Pollack Porter & Joan Benach, 2022. "Deaths of Despair: A Scoping Review on the Social Determinants of Drug Overdose, Alcohol-Related Liver Disease and Suicide," IJERPH, MDPI, vol. 19(19), pages 1-18, September.
    23. Jinho Kim & Sujeong Park & S. V. Subramanian & Taehoon Kim, 2023. "The Psychological Costs of the COVID-19 Pandemic and Heterogeneous Effects in South Korea: Evidence from a Difference-in-Differences Analysis," Journal of Happiness Studies, Springer, vol. 24(2), pages 455-476, February.
    24. Ichiro Kawachi & Ilias Kyriopoulos & Sotiris Vandoros, 2023. "Economic uncertainty and cardiovascular disease mortality," Health Economics, John Wiley & Sons, Ltd., vol. 32(7), pages 1550-1560, July.
    25. Bae, Siye & Jo, Soojin & Shim, Myungkyu, 2023. "United States of Mind under Uncertainty," Journal of Economic Behavior & Organization, Elsevier, vol. 213(C), pages 102-127.
    26. Fabrice Kämpfen & Iliana V Kohler & Alberto Ciancio & Wändi Bruine de Bruin & Jürgen Maurer & Hans-Peter Kohler, 2020. "Predictors of mental health during the Covid-19 pandemic in the US: Role of economic concerns, health worries and social distancing," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-13, November.
    27. Fridh, Maria & Rosvall, Maria & Lindström, Martin, 2020. "Poor psychological health and 5-year suicide mortality: A population-based prospective cohort study," Social Science & Medicine, Elsevier, vol. 258(C).

  8. Petrou, Panagiotis & Vandoros, Sotiris, 2018. "Healthcare reforms in Cyprus 2013–2017: Does the crisis mark the end of the healthcare sector as we know it?," Health Policy, Elsevier, vol. 122(2), pages 75-80.

    Cited by:

    1. Matthias Klumpp & Dominic Loske & Silvio Bicciato, 2022. "COVID-19 health policy evaluation: integrating health and economic perspectives with a data envelopment analysis approach," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(8), pages 1263-1285, November.
    2. Giammanco, Maria Daniela & Gitto, Lara, 2019. "Health expenditure and FDI in Europe," Economic Analysis and Policy, Elsevier, vol. 62(C), pages 255-267.
    3. Olanubi, Oluwanbepelumi Esther & Olanubi, Sijuola Orioye, 2022. "Public sector efficiency in the design of a COVID fund for the euro area," Research in Economics, Elsevier, vol. 76(3), pages 163-169.
    4. Petrou, Panagiotis, 2021. "The 2019 introduction of the new National Healthcare System in Cyprus," Health Policy, Elsevier, vol. 125(3), pages 284-289.

  9. Jofre-Bonet, Mireia & Serra-Sastre, Victoria & Vandoros, Sotiris, 2018. "The impact of the Great Recession on health-related risk factors, behaviour and outcomes in England," Social Science & Medicine, Elsevier, vol. 197(C), pages 213-225.

    Cited by:

    1. Hoang, Dan & Kristoffersen, Ingebjørg & Li, Ian W., 2019. "All in the mind? Estimating the effect of mental health on health behaviours," Social Science & Medicine, Elsevier, vol. 225(C), pages 69-84.
    2. Janke, Katharina & Lee, Kevin & Propper, Carol & Shields, Kalvinder & Shields, Michael A., 2023. "Economic conditions and health: Local effects, national effect and local area heterogeneity," Journal of Economic Behavior & Organization, Elsevier, vol. 214(C), pages 801-828.
    3. Fernández Guerrico, Sofía, 2021. "The effects of trade-induced worker displacement on health and mortality in Mexico," Journal of Health Economics, Elsevier, vol. 80(C).
    4. Papps, Kerry L. & Bryson, Alex & Reade, J. James, 2023. "Running Up That Hill: Fitness in the Face of Recession," IZA Discussion Papers 16410, Institute of Labor Economics (IZA).
    5. Martinez-Jimenez, Mario & Hollingsworth, Bruce & Zucchelli, Eugenio, 2021. "Health, Retirement and Economic Shocks," IZA Discussion Papers 14574, Institute of Labor Economics (IZA).
    6. De Cao, Elisabetta & McCormick, Barry & Nicodemo, Catia, 2022. "Does unemployment worsen babies’ health? A tale of siblings, maternal behaviour, and selection," Journal of Health Economics, Elsevier, vol. 83(C).
    7. Rainer Reile & Aleksei Baburin & Tatjana Veideman & Mall Leinsalu, 2020. "Long-term trends in the body mass index and obesity risk in Estonia: an age–period–cohort approach," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 65(6), pages 859-869, July.
    8. Wang, Qing & Tapia Granados, José A., 2019. "Economic growth and mental health in 21st century China," Social Science & Medicine, Elsevier, vol. 220(C), pages 387-395.
    9. Jonathan Briody & Orla Doyle & Cecily Kelleher, 2019. "The Effect of the Great Recession on Health: A Longitudinal Study of Irish Mothers 2001-2011," Working Papers 201918, School of Economics, University College Dublin.
    10. Jane M Fry & Lisa Farrell, 2023. "Road accidents: unexpected costs of stock market movements," Oxford Economic Papers, Oxford University Press, vol. 75(1), pages 233-255.
    11. Kyriopoulos, Ilias & Nikoloski, Zlatko & Mossialos, Elias, 2019. "The impact of the Greek economic adjustment programme on household health expenditure," Social Science & Medicine, Elsevier, vol. 222(C), pages 274-284.
    12. Vandoros, Sotiris & Avendano, Mauricio & Kawachi, Ichiro, 2019. "The association between economic uncertainty and suicide in the short-run," Social Science & Medicine, Elsevier, vol. 220(C), pages 403-410.
    13. Shamma Adeeb Alam & Bijetri Bose, 2022. "Stepping into adulthood during a recession: Did job losses during the Great Recession impact health of young adults?," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1730-1751, August.
    14. Liew, Tim & Goodwin, Robin & Walasek, Lukasz, 2020. "Voting patterns, revoking article 50 and antidepressant trends in England following the Brexit referendum," Social Science & Medicine, Elsevier, vol. 255(C).
    15. Kyriopoulos, Ilias-Ioannis, 2023. "Economic uncertainty and cardiovascular disease mortality," LSE Research Online Documents on Economics 118452, London School of Economics and Political Science, LSE Library.
    16. Briody, Jonathan & Doyle, Orla & Kelleher, Cecily, 2020. "The effect of local unemployment on health: A longitudinal study of Irish mothers 2001-2011," Economics & Human Biology, Elsevier, vol. 37(C).
    17. Joana Cima & Alvaro S Almeida, 2018. "Health Expenditure, GDP Growth and the Financial Crisis: A Panel Data Analysis for OECD European Countries," FEP Working Papers 602, Universidade do Porto, Faculdade de Economia do Porto.
    18. Chiachi Bonnie Lee & Chen-Mao Liao & Li-Hsin Peng & Chih-Ming Lin, 2019. "Economic fluctuations and cardiovascular diseases: A multiple-input time series analysis," PLOS ONE, Public Library of Science, vol. 14(8), pages 1-19, August.
    19. Nolan, Anne & Smyth, Emer, 2022. "Disrupted transitions: young adults during the COVID-19 pandemic," Research Series, Economic and Social Research Institute (ESRI), number RS142.
    20. Ichiro Kawachi & Ilias Kyriopoulos & Sotiris Vandoros, 2023. "Economic uncertainty and cardiovascular disease mortality," Health Economics, John Wiley & Sons, Ltd., vol. 32(7), pages 1550-1560, July.
    21. Danijela Godinic & Bojan Obrenovic & Akmal Khudaykulov, 2020. "Effects of Economic Uncertainty on Mental Health in the COVID-19 Pandemic Context: Social Identity Disturbance, Job Uncertainty and Psychological Well-Being Model," International Journal of Innovation and Economic Development, Inovatus Services Ltd., vol. 6(1), pages 61-74, April.
    22. Hall, James & Goranitis, Ilias & Kigozi, Jesse & Guariglia, Alessandra, 2021. "New evidence on the impact of the Great Recession on health-compromising behaviours," Economics & Human Biology, Elsevier, vol. 41(C).

  10. van der Windt, Peter & Vandoros, Sotiris, 2017. "Democracy and health: Evidence from within-country heterogeneity in the Congo," Social Science & Medicine, Elsevier, vol. 194(C), pages 10-16.
    See citations under working paper version above.
  11. Petrou, Panagiotis & Vandoros, Sotiris, 2015. "Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment," Health Policy, Elsevier, vol. 119(5), pages 563-568.

    Cited by:

    1. Petrou, Panagiotis & Vandoros, Sotiris, 2018. "Healthcare reforms in Cyprus 2013–2017: Does the crisis mark the end of the healthcare sector as we know it?," Health Policy, Elsevier, vol. 122(2), pages 75-80.
    2. Vogler, Sabine & Zimmermann, Nina & de Joncheere, Kees, 2016. "Policy interventions related to medicines: Survey of measures taken in European countries during 2010–2015," Health Policy, Elsevier, vol. 120(12), pages 1363-1377.
    3. Lars Carlsen & Rainer Bruggemann, 2017. "Fragile State Index: Trends and Developments. A Partial Order Data Analysis," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 133(1), pages 1-14, August.
    4. Petrou, Panagiotis, 2021. "The 2019 introduction of the new National Healthcare System in Cyprus," Health Policy, Elsevier, vol. 125(3), pages 284-289.

  12. Sotiris Vandoros, 2014. "Therapeutic Substitution Post‐Patent Expiry: The Cases Of Ace Inhibitors And Proton Pump Inhibitors," Health Economics, John Wiley & Sons, Ltd., vol. 23(5), pages 621-630, May.

    Cited by:

    1. Petrou, Panagiotis & Vandoros, Sotiris, 2015. "Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment," Health Policy, Elsevier, vol. 119(5), pages 563-568.
    2. Katharina Elisabeth Fischer & Tom Stargardt, 2016. "The diffusion of generics after patent expiry in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(8), pages 1027-1040, November.
    3. Victoria Serra-Sastre & Simona Bianchi & Jorge Mestre-Ferrandiz & Phill O’Neill, 2021. "Does NICE influence the adoption and uptake of generics in the UK?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(2), pages 229-242, March.
    4. Christopher Bates & Susan J. Méndez, 2024. "Therapeutic Substitution in Response to Patent Expiry? Statins in Australia," Economic Papers, The Economic Society of Australia, vol. 43(2), pages 112-123, June.
    5. Gentilini, Arianna & Miraldo, Marisa, 2023. "The role of patient organisations in research and development: Evidence from rare diseases," Social Science & Medicine, Elsevier, vol. 338(C).
    6. Casanova-Juanes, Julieta & Mestre-Ferrandiz, Jorge & Espín-Balbino, Jaime, 2018. "Competition in the off-patent medicine market in Spain: The national reference pricing system versus the regional system of tendering for outpatient prescription medicines in Andalusia," Health Policy, Elsevier, vol. 122(12), pages 1310-1315.
    7. Kanavos, Panos, 2014. "Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States," Health Policy, Elsevier, vol. 118(2), pages 229-241.
    8. Takizawa, Osamu & Urushihara, Hisashi & Tanaka, Shiro & Kawakami, Koji, 2015. "Price difference as a predictor of the selection between brand name and generic statins in Japan," Health Policy, Elsevier, vol. 119(5), pages 612-619.
    9. Sabrina Terrizzi & Chad Meyerhoefer, 2020. "Estimates Of The Price Elasticity Of Switching Between Branded And Generic Drugs," Contemporary Economic Policy, Western Economic Association International, vol. 38(1), pages 94-108, January.
    10. Jędrzej Białkowski & Jeremy Clark, 2022. "The effects of drug safety warnings on drug sales and share prices," Health Economics, John Wiley & Sons, Ltd., vol. 31(1), pages 174-196, January.
    11. Serra-Sastre, Victoria & Bianchi, Simona & Mestre-Ferrandiz, Jorge & O’Neill, Phill, 2021. "Does NICE influence the adoption and uptake of generics in the UK?," LSE Research Online Documents on Economics 113639, London School of Economics and Political Science, LSE Library.

  13. Liu, Guy & Mirzaei, Ali & Vandoros, Sotiris, 2014. "The impact of bank competition and concentration on industrial growth," Economics Letters, Elsevier, vol. 124(1), pages 60-63.

    Cited by:

    1. Tongurai, Jittima & Vithessonthi, Chaiporn, 2018. "The impact of the banking sector on economic structure and growth," International Review of Financial Analysis, Elsevier, vol. 56(C), pages 193-207.
    2. Mirzaei, Ali & Grosse, Robert, 2019. "The interaction of quantity and quality of finance: Did it make industries more resilient to the recent global financial crisis?," International Review of Economics & Finance, Elsevier, vol. 64(C), pages 493-512.
    3. Bogdan Capraru & Nicoleta-Livia Pintilie, 2017. "Assessing competition in the European Union banking sector," The Review of Finance and Banking, Academia de Studii Economice din Bucuresti, Romania / Facultatea de Finante, Asigurari, Banci si Burse de Valori / Catedra de Finante, vol. 9(1), pages 007-026, June.
    4. Igan, Deniz & Mirzaei, Ali, 2020. "Does going tough on banks make the going get tough? Bank liquidity regulations, capital requirements, and sectoral activity," Journal of Economic Behavior & Organization, Elsevier, vol. 177(C), pages 688-726.
    5. Mirzaei, Ali & Al-Khouri, Ritab Salem Farhan, 2016. "The resilience of oil-rich economies to the global financial crisis: Evidence from Kuwaiti financial and real sectors," Economic Systems, Elsevier, vol. 40(1), pages 93-108.
    6. Keil, Jan, 2017. "The trouble with approximating industry concentration from Compustat," Journal of Corporate Finance, Elsevier, vol. 45(C), pages 467-479.
    7. Habib Hussain Khan & Rubi Binit Ahmad & Chan Sok Gee, 2016. "Market Structure, Financial Dependence and Industrial Growth: Evidence from the Banking Industry in Emerging Asian Economies," PLOS ONE, Public Library of Science, vol. 11(8), pages 1-24, August.
    8. Hasan Dinçer & Ozlem Olgu Akdeniz & Umit Hacioglu, 2018. "Competitive strategy selection in the European banking sector using a hybrid decision-making approach," Zbornik radova Ekonomskog fakulteta u Rijeci/Proceedings of Rijeka Faculty of Economics, University of Rijeka, Faculty of Economics and Business, vol. 36(1), pages 213-242.
    9. Wei, Qi & Zeng, Sheng & Tao, Qingmei, 2024. "Does bank competition improve borrower welfare? Evidence from China," Economic Analysis and Policy, Elsevier, vol. 82(C), pages 1353-1368.
    10. Pradeepta Sethi, 2018. "Paradox of external finance in the Indian manufacturing sector," Journal of Financial Economic Policy, Emerald Group Publishing Limited, vol. 10(1), pages 95-111, April.
    11. Tendai Gwatidzo & Witness Simbanegavi, 2024. "Financial inclusion and banking sector competition in South Africa," Working Papers 11061, South African Reserve Bank.

  14. Sotiris Vandoros & Georgios Kavetsos & Paul Dolan, 2014. "Greasy Roads: The Impact of Bad Financial News on Road Traffic Accidents," Risk Analysis, John Wiley & Sons, vol. 34(3), pages 556-566, March.

    Cited by:

    1. Corrado Giulietti & Mirco Tonin & Michael Vlassopoulos, 2018. "When the Market Drives you Crazy: Stock Market Returns and Fatal Car Accidents," CESifo Working Paper Series 7182, CESifo.
    2. French, Michael & Gumus, Gulcin, 2024. "Hit-and-Run or Hit-and-Stay? Unintended Effects of a Stricter BAC Limit," IZA Discussion Papers 16774, Institute of Labor Economics (IZA).
    3. Borowiecki, Karol Jan & Kavetsos, Georgios, 2015. "In fatal pursuit of immortal fame: Peer competition and early mortality of music composers," Discussion Papers on Economics 6/2015, University of Southern Denmark, Department of Economics.
    4. Jofre-Bonet, M. & Serra-Sastre, V. & Vandoros, S., 2016. "Better Health in Times of Hardship?," Working Papers 16/09, Department of Economics, City University London.
    5. Li, Fudong & Zhong, Jieming & He, Fan & Wang, Hao & Lin, Junfen & Yu, Min, 2022. "Stock market fluctuation and stroke incidence: A time series study in Eastern China," Social Science & Medicine, Elsevier, vol. 296(C).
    6. Kanavos, Panos & Vandoros, Sotiris, 2023. "Road traffic mortality and economic uncertainty: Evidence from the United States," Social Science & Medicine, Elsevier, vol. 326(C).
    7. Vandoros, Sotiris & Avendano, Mauricio & Kawachi, Ichiro, 2019. "The association between economic uncertainty and suicide in the short-run," Social Science & Medicine, Elsevier, vol. 220(C), pages 403-410.
    8. Nikolaos Antonakakis & Nikolaos Antonakakis & Alan Collins, 2014. "Does Fiscal Consolidation Really Get You Down? Evidence from Suicide Mortality," Department of Economics Working Papers wuwp182, Vienna University of Economics and Business, Department of Economics.
    9. Antonakakis, Nikolaos & Collins, Alan, 2015. "The impact of fiscal austerity on suicide mortality: Evidence across the ‘Eurozone periphery’," Social Science & Medicine, Elsevier, vol. 145(C), pages 63-78.

  15. Sotiris Vandoros & Panos Kanavos, 2014. "Parallel Trade and Pharmaceutical Prices: A Game-theoretic Approach and Empirical Evidence from the European Union," The World Economy, Wiley Blackwell, vol. 37(6), pages 856-880, June.

    Cited by:

    1. David Granlund, 2022. "Direct and indirect savings from parallel imports in Sweden," Health Economics Review, Springer, vol. 12(1), pages 1-14, December.
    2. Adrian Towse & Michele Pistollato & Jorge Mestre-Ferrandiz & Zeba Khan & Satyin Kaura & Louis Garrison, 2015. "European Union Pharmaceutical Markets: A Case for Differential Pricing?," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 263-275, July.

  16. Sotiris Vandoros, 2013. "My five pounds are not as good as yours, so I will spend them," Experimental Economics, Springer;Economic Science Association, vol. 16(4), pages 546-559, December.

    Cited by:

    1. David Fielding & Stephen Knowles, 2013. "Can You Spare Some Change For Charity? Experimental Evidence On Verbal Cues And Loose Change Effects In A Dictator Game," Working Papers 1318, University of Otago, Department of Economics, revised Nov 2013.
    2. Runnemark, Emma & Hedman, Jonas & Xiao, Xiao, 2014. "Do Consumers Pay More Using Debit Cards than Cash? An Experiment," Working Papers 2014:21, Lund University, Department of Economics.
    3. Jessica B. Hoel & Prachi Jain & Bridget Galaty, 2022. "JUST VENMO ME: Does form of payment affect risk taking and intertemporal choice?," Journal of the Economic Science Association, Springer;Economic Science Association, vol. 8(1), pages 16-33, December.
    4. Roy, Rajat & Das, Gopal, 2022. "The role of contextual factors in increasing Pay-What-You-Want payments: Evidence from field experiments," Journal of Business Research, Elsevier, vol. 139(C), pages 1540-1552.
    5. Junyi Shen & Hiromasa Takahashi, 2015. "The Tangibility Effect of Paper Money and Coins in an Investment Experiment," Discussion Paper Series DP2015-41, Research Institute for Economics & Business Administration, Kobe University.

  17. Sotiris Vandoros & Panos Kanavos, 2013. "The generics paradox revisited: empirical evidence from regulated markets," Applied Economics, Taylor & Francis Journals, vol. 45(22), pages 3230-3239, August.

    Cited by:

    1. Micael Castanheira De Moura & Carmine Ornaghi & Georges Siotis, 2019. "The Unexpected Consequences of Generic Entry," Working Papers ECARES 2019-21, ULB -- Universite Libre de Bruxelles.
    2. Porath, Daniel, 2016. "Size and dynamics of order-of-entry effects in pharmaceutical markets," UASM Discussion Paper Series 4/2016, University of Applied Sciences Mainz.
    3. Arvate, Paulo Roberto & Barbosa, Klênio & Gambardella, Dante, 2013. "Generic-branded drug competition and the price for pharmaceuticals in procurement auctions," Textos para discussão 333, FGV EESP - Escola de Economia de São Paulo, Fundação Getulio Vargas (Brazil).
    4. Katharina Elisabeth Fischer & Tom Stargardt, 2016. "The diffusion of generics after patent expiry in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(8), pages 1027-1040, November.
    5. Michael Mueller & Alexander Frenzel, 2015. "Competitive pricing within pharmaceutical classes: evidence on “follow-on” drugs in Germany 1993–2008," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(1), pages 73-82, January.
    6. Carneiro, Livia Mendes & Eid Junior, William & Yoshinaga, Claudia Emiko, 2022. "The implications of passive investments for active fund management: International evidence," Global Finance Journal, Elsevier, vol. 53(C).
    7. Siotis, Georges & Castanheira, Micael & de Frutos, Maria-Angeles & Ornaghi, Carmine, 2017. "The Unexpected Consequences of Asymmetric Competition. An Application to Big Pharma," CEPR Discussion Papers 11813, C.E.P.R. Discussion Papers.
    8. Vandoros, Sotiris & Stargardt, Tom, 2013. "Reforms in the Greek pharmaceutical market during the financial crisis," Health Policy, Elsevier, vol. 109(1), pages 1-6.
    9. Sotiris Vandoros, 2014. "Therapeutic Substitution Post‐Patent Expiry: The Cases Of Ace Inhibitors And Proton Pump Inhibitors," Health Economics, John Wiley & Sons, Ltd., vol. 23(5), pages 621-630, May.
    10. Puig-Junoy, Jaume & López-Valcárcel, Beatriz González, 2014. "Launch prices for new pharmaceuticals in the heavily regulated and subsidized Spanish market, 1995–2007," Health Policy, Elsevier, vol. 116(2), pages 170-181.
    11. Kanavos, Panos, 2014. "Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States," Health Policy, Elsevier, vol. 118(2), pages 229-241.
    12. Costa-Font, Joan & Rudisill, Caroline & Tan, Stefanie, 2014. "Brand loyalty, patients and limited generic medicines uptake," Health Policy, Elsevier, vol. 116(2), pages 224-233.
    13. Thomas M. Fullerton & Steven L. Fullerton, 2022. "Aggregate Online Brand Name Pharmacy Price Dynamics for the United States and Mexico," Economies, MDPI, vol. 10(5), pages 1-5, May.

  18. Vandoros, Sotiris & Stargardt, Tom, 2013. "Reforms in the Greek pharmaceutical market during the financial crisis," Health Policy, Elsevier, vol. 109(1), pages 1-6.

    Cited by:

    1. Balasopoulos, T. & Charonis, A. & Athanasakis, K. & Kyriopoulos, J. & Pavi, E., 2017. "Why do generic drugs fail to achieve an adequate market share in Greece? Empirical findings and policy suggestions," Health Policy, Elsevier, vol. 121(3), pages 265-272.
    2. Ifanti, Amalia A. & Argyriou, Andreas A. & Kalofonou, Foteini H. & Kalofonos, Haralabos P., 2013. "Financial crisis and austerity measures in Greece: Their impact on health promotion policies and public health care," Health Policy, Elsevier, vol. 113(1), pages 8-12.
    3. Greta Falavigna & Roberto Ippoliti & Marinella Bertolotti & Franca Riva & Antonio Maconi, 2017. "Supportare la ricerca e l’innovazione in sanità tramite i modelli organizzativi: il caso dell’Azienda Ospedaliera “SS. Antonio e Biagio e Cesare Arrigo” di Alessandria/Supporting research and innovati," IRCrES Working Paper 201709, CNR-IRCrES Research Institute on Sustainable Economic Growth - Moncalieri (TO) ITALY - former Institute for Economic Research on Firms and Growth - Torino (TO) ITALY.
    4. Lei Chen & Ying Yang & Mi Luo & Borui Hu & Shicheng Yin & Zongfu Mao, 2020. "The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China," IJERPH, MDPI, vol. 17(24), pages 1-11, December.
    5. Simou, Effie & Koutsogeorgou, Eleni, 2014. "Effects of the economic crisis on health and healthcare in Greece in the literature from 2009 to 2013: A systematic review," Health Policy, Elsevier, vol. 115(2), pages 111-119.
    6. George Fragkiadakis & Michael Doumpos & Constantin Zopounidis & Christophe Germain, 2016. "Operational and economic efficiency analysis of public hospitals in Greece," Annals of Operations Research, Springer, vol. 247(2), pages 787-806, December.
    7. Tapia Granados, José A. & Rodriguez, Javier M., 2015. "Health, economic crisis, and austerity: A comparison of Greece, Finland and Iceland," Health Policy, Elsevier, vol. 119(7), pages 941-953.
    8. Petrou, Panagiotis & Vandoros, Sotiris, 2015. "Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment," Health Policy, Elsevier, vol. 119(5), pages 563-568.
    9. Casagranda, Ivo & Costantino, Giorgio & Falavigna, Greta & Furlan, Raffaello & Ippoliti, Roberto, 2016. "Artificial Neural Networks and risk stratification models in Emergency Departments: The policy maker's perspective," Health Policy, Elsevier, vol. 120(1), pages 111-119.
    10. Cavalieri, Marina & Guccio, Calogero & Rizzo, Ilde, 2017. "On the role of environmental corruption in healthcare infrastructures: An empirical assessment for Italy using DEA with truncated regression approach," Health Policy, Elsevier, vol. 121(5), pages 515-524.
    11. Jaume Puig-Junoy & Santiago Rodríguez-Feijoó & Beatriz Lopez-Valcarcel, 2014. "Paying for Formerly Free Medicines in Spain After 1 Year of Co-Payment: Changes in the Number of Dispensed Prescriptions," Applied Health Economics and Health Policy, Springer, vol. 12(3), pages 279-287, June.
    12. Goranitis, Ilias & Siskou, Olga & Liaropoulos, Lycourgos, 2014. "Health policy making under information constraints: An evaluation of the policy responses to the economic crisis in Greece," Health Policy, Elsevier, vol. 117(3), pages 279-284.
    13. Quaglio, GianLuca & Karapiperis, Theodoros & Van Woensel, Lieve & Arnold, Elleke & McDaid, David, 2013. "Austerity and health in Europe," Health Policy, Elsevier, vol. 113(1), pages 13-19.
    14. Vogler, Sabine & Zimmermann, Nina & de Joncheere, Kees, 2016. "Policy interventions related to medicines: Survey of measures taken in European countries during 2010–2015," Health Policy, Elsevier, vol. 120(12), pages 1363-1377.
    15. Nikolaos Polyzos & Catherine Kastanioti & Christos Zilidis & George Mavridoglou & Stefanos Karakolias & Panagiota Litsa & Valantis Menegakis & Chara Kani, 2016. "Greek National E-Prescribing System: Preliminary Results of a Tool for Rationalizing Pharmaceutical Use and Cost," Global Journal of Health Science, Canadian Center of Science and Education, vol. 8(10), pages 241-241, October.
    16. George Fragkiadakis & Michael Doumpos & Constantin Zopounidis & Christophe Germain, 2016. "Operational and economic efficiency analysis of public hospitals in Greece," Post-Print hal-01414677, HAL.
    17. Mastorakis, Kostis & Siskos, Eleftherios, 2016. "Value focused pharmaceutical strategy determination with multicriteria decision analysis techniques," Omega, Elsevier, vol. 59(PA), pages 84-96.

  19. Kanavos, Panos G. & Vandoros, Sotiris, 2011. "Determinants of branded prescription medicine prices in OECD countries," Health Economics, Policy and Law, Cambridge University Press, vol. 6(3), pages 337-367, July.
    See citations under working paper version above.
  20. Bertoldi, A.D. & Barros, A.J.D. & Camargo, A.L. & Hallal, P.C. & Vandoros, S. & Wagner, A. & Ross-Degnan, D., 2011. "Household expenditures for medicines and the role of free medicines in the brazilian public health system," American Journal of Public Health, American Public Health Association, vol. 101(5), pages 916-921.

    Cited by:

    1. Eduardo J. Gómez, 2016. "Confronting Health Inequalities in the BRICS: Political Institutions, Foreign Policy Aspirations and State-civil Societal Relationships," Global Policy, London School of Economics and Political Science, vol. 7(4), pages 500-509, November.

  21. Fritz von der Schulenburg & Sotiris Vandoros & Panos Kanavos, 2011. "The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors," Health Economics Review, Springer, vol. 1(1), pages 1-8, December.

    Cited by:

    1. Espinosa, Oscar & Rodríguez, Jhonathan & Ávila, Diego & Rodríguez-Lesmes, Paul & Basto, Sergio & Romano, Giancarlo & Mesa, Lorena & Enríquez, Hernán, 2023. "The impact of updating health benefits plans on health technologies usage and expenditures: the case of Colombia," Documentos de Trabajo 20821, Universidad del Rosario.
    2. Joosse, Iris R. & Tordrup, David & Glanville, Julie & Mantel-Teeuwisse, Aukje K. & van den Ham, Hendrika A., 2023. "A systematic review of policies regulating or removing mark-ups in the pharmaceutical supply and distribution chain," Health Policy, Elsevier, vol. 138(C).
    3. Nika Marđetko & Mitja Kos, 2018. "Introduction of therapeutic reference pricing in Slovenia and its economic consequences," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(4), pages 571-584, May.
    4. Joosse, Iris R. & Tordrup, David & Bero, Lisa & Mantel-Teeuwisse, Aukje K. & van den Ham, Hendrika A., 2023. "A critical review of methodologies used in pharmaceutical pricing policy analyses," Health Policy, Elsevier, vol. 134(C).
    5. Sotiris Vandoros, 2014. "Therapeutic Substitution Post‐Patent Expiry: The Cases Of Ace Inhibitors And Proton Pump Inhibitors," Health Economics, John Wiley & Sons, Ltd., vol. 23(5), pages 621-630, May.
    6. Andia, Tatiana & Mantilla, Cesar & Morales, Alvaro & Ortiz, Santiago & Rodriguez-Lesmes, Paul, 2020. "Does price-cap regulation work for increasing access to contraceptives? Aggregate- and pharmacy-level evidence from Colombia," SocArXiv cq7d2, Center for Open Science.
    7. Gentilini, Arianna & Miraldo, Marisa, 2023. "The role of patient organisations in research and development: Evidence from rare diseases," Social Science & Medicine, Elsevier, vol. 338(C).
    8. Park, Sun-Young & Han, Euna & Kim, Jini & Lee, Eui-Kyung, 2016. "Factors influencing the difference between forecasted and actual drug sales volumes under the price–volume agreement in South Korea," Health Policy, Elsevier, vol. 120(8), pages 867-874.
    9. Adrian Towse & Michele Pistollato & Jorge Mestre-Ferrandiz & Zeba Khan & Satyin Kaura & Louis Garrison, 2015. "European Union Pharmaceutical Markets: A Case for Differential Pricing?," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 263-275, July.
    10. Tomasz Zaprutko & Dorota Kopciuch & Krzysztof Kus & Piotr Merks & Monika Nowicka & Izabela Augustyniak & Elżbieta Nowakowska, 2017. "Affordability of medicines in the European Union," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-13, February.
    11. Carone, Giuseppe & Schwierz, Christoph & Xavier, Ana, 2012. "Cost-containment policies in public pharmaceutical spending in the EU," MPRA Paper 42008, University Library of Munich, Germany.
    12. Fabio Pammolli & Armando Rungi, 2016. "Access to Medicines and European Market Integration," Working Papers 01/2016, IMT School for Advanced Studies Lucca, revised Jan 2016.
    13. Massimo Florio & Chiara Pancotti, 2022. "European pharmaceutical research and development. Could a public infrastructure overcome market failures?," Working Papers 202202, CSIL Centre for Industrial Studies.
    14. Stephan Eger & Jörg Mahlich, 2014. "Pharmaceutical regulation in Europe and its impact on corporate R&D," Health Economics Review, Springer, vol. 4(1), pages 1-9, December.
    15. Dominik J. Wettstein & Stefan Boes, 2019. "Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review," Applied Health Economics and Health Policy, Springer, vol. 17(2), pages 143-162, April.
    16. Leopold, Christine & Mantel-Teeuwisse, Aukje Katja & Vogler, Sabine & de Joncheere, Kees & Laing, Richard Ogilvie & Leufkens, Hubert G.M., 2013. "Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries," Health Policy, Elsevier, vol. 112(3), pages 209-216.

  22. Panos Kanavos & Sotiris Vandoros, 2010. "Competition in prescription drug markets: is parallel trade the answer?," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 31(5), pages 325-338.

    Cited by:

    1. Dubois, Pierre & Saethre, Morten, 2018. "On the Effect of Parallel Trade on Manufacturers' and Retailers' Profits in the Pharmaceutical Sector," CEPR Discussion Papers 12649, C.E.P.R. Discussion Papers.
    2. David Granlund & Miyase Koksal-Ayhan, 2015. "Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(9), pages 969-983, December.
    3. Hostenkamp, Gisela & Kronborg, Christian & Arendt, Jacob Nielsen, 2012. "Parallel imports of hospital pharmaceuticals: An empirical analysis of price effects from parallel imports and the design of procurement procedures in the Danish hospital sector," Discussion Papers on Economics 16/2012, University of Southern Denmark, Department of Economics.
    4. Duso, T. & Herr, A. & Suppliet, M, 2014. "The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics," Health, Econometrics and Data Group (HEDG) Working Papers 14/09, HEDG, c/o Department of Economics, University of York.
    5. David Granlund, 2022. "Direct and indirect savings from parallel imports in Sweden," Health Economics Review, Springer, vol. 12(1), pages 1-14, December.
    6. Granlund David & Köksal-Ayhan Miyase Yesim, 2016. "EU Enlargement, Parallel Trade and Price Competition in Pharmaceuticals: Has the Price Competition increased?," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 16(2), pages 1069-1092, April.
    7. David Granlund, 2022. "The Price Effects of Competition from Parallel Imports and Therapeutic Alternatives: Using Dynamic Models to Estimate the Causal Effect on the Extensive and Intensive Margins," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 60(1), pages 63-92, February.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.